Silence Therapeutics plc (SLNCF)
OTCMKTS · Delayed Price · Currency is USD
1.600
0.00 (0.00%)
Sep 4, 2025, 8:00 PM EDT

Silence Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
269325672547715611
Upgrade
Market Cap Growth
-69.07%-51.64%22.71%-23.44%17.04%-
Upgrade
Enterprise Value
155152600448612549
Upgrade
Last Close Price
1.602.631.503.257.156.97
Upgrade
PS Ratio
9.897.5121.2325.2842.5381.67
Upgrade
PB Ratio
2.852.4230.5420.5861.9349.39
Upgrade
P/TBV Ratio
3.232.6157.6633.06580.25487.96
Upgrade
P/FCF Ratio
----96.09-
Upgrade
P/OCF Ratio
----77.58-
Upgrade
EV/Sales Ratio
5.693.5218.9720.6736.4073.34
Upgrade
EV/FCF Ratio
-1.77---82.24-
Upgrade
Debt / Equity Ratio
-0.000.020.020.020.04
Upgrade
Debt / FCF Ratio
----0.03-
Upgrade
Asset Turnover
0.140.270.250.180.140.08
Upgrade
Quick Ratio
9.0910.364.154.035.412.78
Upgrade
Current Ratio
10.0611.144.624.415.692.99
Upgrade
Return on Equity (ROE)
-66.96%-58.08%-223.22%-273.06%-448.22%-217.21%
Upgrade
Return on Assets (ROA)
-22.25%-19.24%-26.32%-26.09%-31.44%-29.33%
Upgrade
Return on Capital (ROIC)
-37.96%-39.61%-132.49%-170.42%-317.04%-126.58%
Upgrade
Earnings Yield
-29.44%-13.95%-8.07%-9.20%-7.46%-7.27%
Upgrade
FCF Yield
-32.50%-20.89%-7.37%-10.45%1.04%-2.52%
Upgrade
Buyback Yield / Dilution
-13.08%-24.69%-15.21%-8.58%-8.78%-8.85%
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.